Home/Filings/4/0001209191-23-039960
4//SEC Filing

Sandborn William J. 4

Accession 0001209191-23-039960

CIK 0001851194other

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 6:01 PM ET

Size

12.2 KB

Accession

0001209191-23-039960

Insider Transaction Report

Form 4
Period: 2023-06-23
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-06-2310,7900 total
    Exercise: $0.20Exp: 2029-03-27Common Stock (10,790 underlying)
  • Sale

    Common Stock

    2023-06-23$32.85/sh8,675$284,95248,389 total
  • Exercise/Conversion

    Common Stock

    2023-06-23$0.20/sh+10,790$2,15859,179 total
  • Sale

    Common Stock

    2023-06-23$32.10/sh2,115$67,89257,064 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    31,175
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 19, 2022.
  • [F2]Represents the weighted average share price of an aggregate total of 2,115 shares sold in the price range of $31.51 to $32.4136. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Represents the weighted average share price of an aggregate total of 8,675 shares sold in the price range of $32.5854 to $33.5094. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Subject to the Reporting Person's spouse continuing to be a Service Provider (as defined in the Issuer's 2019 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 6, 2019.

Issuer

Ventyx Biosciences, Inc.

CIK 0001851194

Entity typeother

Related Parties

1
  • filerCIK 0001923805

Filing Metadata

Form type
4
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 6:01 PM ET
Size
12.2 KB